Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (4,372) Arrow Down
Filter Results: (4,372) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (4,372)
    • People  (14)
    • News  (1,531)
    • Research  (2,275)
    • Events  (1)
    • Multimedia  (155)
  • Faculty Publications  (1,788)

Show Results For

  • All HBS Web  (4,372)
    • People  (14)
    • News  (1,531)
    • Research  (2,275)
    • Events  (1)
    • Multimedia  (155)
  • Faculty Publications  (1,788)
← Page 81 of 4,372 Results →
  • 18 Dec 2020
  • News

Making Doctors Effective Managers and Leaders

  • Web

Events & Presentations - Institute For Strategy And Competitiveness

competitiveness, strategies for business, creating shared value, and other topics. Recent & Upcoming Events November 16-18, 2022 November 2022 Strategy for Health Care Delivery... View Details
  • 12 Dec 2023
  • Blog Post

Bridging Science and Business: My Summer Internship at Eli Lilly

Earlier this year, I had the incredible opportunity to further cultivate my intersecting interests during a transformative internship at Eli Lilly. It wasn't just a summer of tasks and projects—it was an experience that tied together my... View Details
  • 2023
  • Working Paper

The Political Economy of a 'Miracle Cure': The Case of Nebulized Ibuprofen and Its Diffusion in Argentina

By: Sebastian Calónico, Rafael Di Tella and Juan Cruz Lopez Del Valle
We document the diffusion of nebulized ibuprofen in Argentina as a treatment for COVID-19. As the pandemic spread, this clinically unsupported drug reached thousands of patients, even some seriously ill, despite warnings by the regulator and medical societies. Detailed... View Details
Keywords: COVID-19; Health Care and Treatment; Health Pandemics; Adoption; Behavior; Governing Rules, Regulations, and Reforms; Learning
Citation
Find at Harvard
Register to Read
Related
Calónico, Sebastian, Rafael Di Tella, and Juan Cruz Lopez Del Valle. "The Political Economy of a 'Miracle Cure': The Case of Nebulized Ibuprofen and Its Diffusion in Argentina." NBER Working Paper Series, No. 31781, October 2023.
  • 23 Mar 2010
  • News

Harvard Business School Faculty on the Passage of U.S. Healthcare Reform Legislation

  • Article

Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology

By: Palak Kundu, Olivia Jung, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg and Ann Raldow
Background
Psychological safety, a shared belief that interpersonal risk taking is safe, is an important determinant of incident reporting. However, how psychological safety affects near-miss reporting is unclear, as near misses contain contrasting cues that... View Details
Keywords: Psychological Safety; Near-miss Reporting; Health Care and Treatment; Safety
Citation
Read Now
Related
Kundu, Palak, Olivia Jung, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg, and Ann Raldow. "Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology." Joint Commission Journal on Quality and Patient Safety 47, no. 1 (January 2021): 15–22.
  • Article

Dissecting Costs of CT Study: Application of TDABC (Time-driven Activity-based Costing) in a Tertiary Academic Center

By: Robert S. Kaplan, Yoshimi Anzai, Marta E. Heilbrun, Derek Haas, Luca Boi, Kirk Moshre, Satoshi Minoshima and Vivian S. Lee
The lack of understanding the true costs (not charges) of delivering health care services poses tremendous challenges in the containment of health care costs. In this study, we applied an established cost accounting method, time-driven activity-based costing (TDABC),... View Details
Keywords: Healthcare Costs; Medical Imaging; Computed Tomography; Activity-Based Costing; Cost Accounting; Activity Based Costing and Management; Health Care and Treatment; Performance Efficiency; Health Industry
Citation
Read Now
Related
Kaplan, Robert S., Yoshimi Anzai, Marta E. Heilbrun, Derek Haas, Luca Boi, Kirk Moshre, Satoshi Minoshima, and Vivian S. Lee. "Dissecting Costs of CT Study: Application of TDABC (Time-driven Activity-based Costing) in a Tertiary Academic Center." Academic Radiology 24, no. 2 (February 2017): 200–208.
  • 06 Sep 2019
  • Blog Post

The Business of Medicine: MD/MBA Students Having an Impact

change both small and large: improving how operating rooms function, and “instituting changes from an administrative perspective” that would address socioeconomic inequalities. All with the goal of changing... View Details
  • Web

Aligning Reimbursement with Value - Institute For Strategy And Competitiveness

Measure Outcomes & Cost for Every Patient Aligning Reimbursement with Value Systems Integration Geography of Care Information Technology Aligning Reimbursement w... Aligning Reimbursement with Value Value-based View Details
  • 12 Mar 2014
  • Research & Ideas

Entrepreneurship and Multinationals Drive Globalization

War I, the management of political risk became a central concern for firms operating internationally. These risks were on many levels, from expropriation to exchange controls and other economic policies. The issue is explored in multiple... View Details
Keywords: by Sean Silverthorne; Beauty & Cosmetics; Manufacturing; Consumer Products; Pharmaceutical
  • October 1996 (Revised May 2001)
  • Case

Cantuga Farmworkers Clinic (A)

By: James E. Austin and Catherine Overholt
The board of directors of a rural health clinic fires its executive director. The case elaborates the evolution and progress of the clinic under this director during a period of growth and a changing health care environment. Factors contributing to and questioning the... View Details
Keywords: Health Care and Treatment; Resignation and Termination; Managerial Roles; Organizational Change and Adaptation; Performance Evaluation; Problems and Challenges; Rank and Position; Social Enterprise; Health Industry
Citation
Educators
Purchase
Related
Austin, James E., and Catherine Overholt. "Cantuga Farmworkers Clinic (A)." Harvard Business School Case 797-041, October 1996. (Revised May 2001.)
  • 2023
  • Working Paper

When Should Public Programs Be Privately Administered? Theory and Evidence from the Paycheck Protection Program

By: Alexander Bartik, Zoë B. Cullen, Edward L. Glaeser, Michael Luca, Christopher Stanton and Adi Sunderam
What happens when public resources are allocated by private companies whose objectives may be imperfectly aligned with policy goals? We study this question in the context of the Paycheck Protection Program (PPP), which relied on private banks to disburse aid to small... View Details
Keywords: Paycheck Protection Program; Targeting; Impact; Entrepreneurship; Health Pandemics; Small Business; Financing and Loans; Outcome or Result; United States
Citation
SSRN
Read Now
Related
Bartik, Alexander, Zoë B. Cullen, Edward L. Glaeser, Michael Luca, Christopher Stanton, and Adi Sunderam. "When Should Public Programs Be Privately Administered? Theory and Evidence from the Paycheck Protection Program." Harvard Business School Working Paper, No. 21-021, August 2020. (Revised July 2023. Accepted at The Review of Economics and Statistics.)
  • January 2024
  • Article

A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder

By: Sarah E. Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe and Robert S. Kaplan
The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic’s ability to expand and improve access, especially for socially marginalized patients with... View Details
Keywords: Health Care and Treatment; Cost; Equality and Inequality; Health Industry
Citation
Find at Harvard
Purchase
Related
Wakeman, Sarah E., Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe, and Robert S. Kaplan. "A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder." Journal of Behavioral Health Services & Research 51, no. 1 (January 2024): 22–30.
  • 23 Jul 2021
  • News

The Cost of the Olympics’ ‘Runaway Arms Race’ and New Hope for Student Loan Borrowers in Bankruptcy

  • 22 May 2020
  • News

What Hospitals Overwhelmed by Covid-19 Can Learn From Startups

  • 2021
  • Working Paper

Regulatory Approval and Expanded Market Size

By: Benjamin Berger, Amitabh Chandra and Craig Garthwaite
Regulatory review of new medicines is often viewed as a hindrance to innovation by increasing the hurdle to bring products to market. However, a more complete accounting of regulation must also account for its potential market expanding effects through quality... View Details
Keywords: New Medicines; Regulatory Approval; Health Care and Treatment; Research and Development; Governing Rules, Regulations, and Reforms; Markets; Expansion; Pharmaceutical Industry
Citation
Find at Harvard
Read Now
Related
Berger, Benjamin, Amitabh Chandra, and Craig Garthwaite. "Regulatory Approval and Expanded Market Size." NBER Working Paper Series, No. 28889, June 2021.
  • 10 Jun 2021
  • News

Preparing Hospitals for the Next Pandemic

  • 24 Mar 2011
  • Working Paper Summaries

Individual Rationality and Participation in Large Scale, Multi-Hospital Kidney Exchanges

Keywords: by Itai Ashlagi & Alvin E. Roth; Health
  • August 2008 (Revised September 2008)
  • Supplement

The Flaxil Label (C): Debrief and Endnotes

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Safety; Value Creation; Negotiation; Health Care and Treatment; Sales; Pharmaceutical Industry
Citation
Purchase
Related
Barron, Greg M. "The Flaxil Label (C): Debrief and Endnotes." Harvard Business School Supplement 909-003, August 2008. (Revised September 2008.)
  • May 11, 2017
  • Article

Good Riddance to Big Insurance Mergers

By: Leemore S. Dafny
Federal judges issued preliminary injunctions halting mergers of four of the five largest U.S. health insurers. These decisions provide more precedent to support challenges of mergers between competitors in health care markets—whether payers or providers. View Details
Keywords: Mergers and Acquisitions; Insurance; Health Care and Treatment; Health Industry; Health Industry
Citation
Find at Harvard
Related
Dafny, Leemore S. "Good Riddance to Big Insurance Mergers." New England Journal of Medicine 376, no. 19 (May 11, 2017): 1804–1806.
  • ←
  • 81
  • 82
  • …
  • 218
  • 219
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.